Mounjaro®

MOUNJARO^® (tirzepatide) is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.

This treatment requires a prescription.
Complete our online assessment to check eligibility and access treatment.

Mounjaro KwikPen (USA FDA & MOH Approved)
Active Ingredient: Tirzepatide
Each pen contains 4 shots (1 shot to be taken per week)
Needles & Alcohol Swabs Included
Prescription will be provided, subject to eligibility

Ingredients

How to use

Once weekly – It has to be administered on the same day each week, any time of day, with or without food.
Inject Mounjaro under the skin in your stomach area, thigh or upper arm once a week using an injection pen.
Don’t worry, it’s actually much easier than it sounds and we’ll provide you with full instructions on how to use it.
You must follow a strict dosage as advised by your healthcare provider.

How does this product work?

MOUNJARO^® (tirzepatide) is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Limitations of Use:

Co-administration with other tirzepatide-containing products or GLP-1 receptor agonist is not recommended.
MOUNJARO^® has not been studied in patients with a history of pancreatitis.
MOUNJARO^® is not indicated for use in patients with type 1 diabetes mellitus.